|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents (includes interest-bearing deposits with other banks of $28,135 and $10,380 at June 30, 2026 and June 30, 2025, respectively) | ||||||||||||||||||||
| Securities available-for-sale (amortized cost June 30, 2026: $45,980; June 30, 2025: $36,695, respectively) | ||||||||||||||||||||
| Securities held-to-maturity (fair value June 30, 2026: $46,658; June 30, 2025: $51,139, respectively) | ||||||||||||||||||||
| Other securities | ||||||||||||||||||||
| Loans held-for-sale | ||||||||||||||||||||
| Loans receivable, net of allowance for credit losses (June 30, 2026: $4,926; June 30, 2025: $4,484, respectively) | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core deposit intangible | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Real estate owned | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Non-interest bearing | ||||||||||||||||||||
| Interest bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Advances from borrowers for taxes and insurance | ||||||||||||||||||||
| Short-term Federal Home Loan Bank Advances | ||||||||||||||||||||
| Advances from the Federal Home Loan Bank of Dallas | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Other accrued expenses and liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Preferred stock - $0.01 par value; 10,000,000 shares authorized: none issued and outstanding | ||||||||||||||||||||
| Common stock - $0.01 par value; 40,000,000 shares authorized: 3,042,451 and 3,084,764 shares issued and outstanding at June 30, 2026 and June 30, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Unearned ESOP stock | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
